# LGM Pharma Solutions, LLC – FDA Inspection, Aug 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/ca7148c1-4596-4434-a574-793ec136f744
Source feed: FDA_Inspections

> FDA inspection 1062404 of LGM Pharma Solutions, LLC, August 17, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 314. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062404
- Company Name: LGM Pharma Solutions, LLC
- Inspection Date: 2018-08-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1317740 - 2026-05-18](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/862f3c9a-5369-473a-b4fe-259a971eb45c)
- FDA Inspection 1232056 - 2025-01-24
- [FDA Inspection 1230374 - 2024-03-01](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/1d4efc76-d6cb-4820-a2a8-d28f1e3bc96a)
- FDA Inspection 1120565 - 2020-01-31
- [FDA Inspection 1029466 - 2017-10-20](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/bec6dcf5-e6db-4838-a7c9-aa6757434988)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/angela-shepas/743113c1-799b-44e9-9422-8049c476bfd2)
- Issuing Officer

Company: https://www.keypedia.com/companies/lgm-pharma-solutions-llc/5ee22c42-8e6e-4af9-a2b7-832e0d586f19

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c